Athersys Inc (NASDAQ:ATHX)

2.47
Delayed Data
As of May 25
 +0.02 / +0.82%
Today’s Change
1.29
Today|||52-Week Range
2.63
+36.46%
Year-to-Date
BioMarin's Palynziq Gets FDA Approval for Phenylketonuria
May 25 / Zacks.com - Paid Partner Content
Moving Average Crossover Alert: Athersys, Inc. (ATHX)
May 22 / Zacks.com - Paid Partner Content
INSYS Gets Negative FDA Recommendation for Pain Candidate
May 23 / Zacks.com - Paid Partner Content